Publications by authors named "Jonathan McCone"

Claim this Profile
O
Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials.
Michael P Manns, Jonathan McCone, Mitchell N Davis, Lorenzo Rossaro, Eugene Schiff

Liver Int· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response.
John M Vierling, Mitchell Davis, Steven Flamm, Stuart C Gordon, Eric Lawitz, Jonathan McCone

J Hepatol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial.
Robert A Ogert, John A Howe, John M Vierling, Paul Y Kwo, Eric J Lawitz, Jonathan McCone

Antivir Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
Alexander J Thompson, Paul J Clark, Abanish Singh, Dongliang Ge, Jacques Fellay, Jonathan McCone

J Hepatol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial differences in hepatitis C treatment eligibility.
Michael T Melia, Andrew J Muir, Jonathan McCone, Mitchell L Shiffman, John W King

Hepatology· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boceprevir for untreated chronic HCV genotype 1 infection.
Fred Poordad, Jonathan McCone, Bruce R Bacon, Savino Bruno, Michael P Manns

N Engl J Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate.
Mark S Sulkowski, Mitchell L Shiffman, Nezam H Afdhal, K Rajender Reddy, Jonathan McCone

Gastroenterology· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.
Paul Y Kwo, Eric J Lawitz, Jonathan McCone, Eugene R Schiff, John M Vierling

Lancet· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.
Alexander J Thompson, Andrew J Muir, Mark S Sulkowski, Dongliang Ge, Jacques Fellay, Jonathan McCone

Gastroenterology· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.
John G McHutchison, Eric J Lawitz, Mitchell L Shiffman, Andrew J Muir, Greg W Galler, Jonathan McCone

N Engl J Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of weight-based ribavirin with peginterferon alfa-2b in African Americans with hepatitis C virus genotype 1.
Ira M Jacobson, Robert S Brown, Jonathan McCone, Martin Black, Clive Albert

Hepatology· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of IL-1Ra in resistant and responsive hepatitis C patients following treatment with IFN-con1.
Scott J Cotler, Teresa Craft, Mary Ferris, Mary Morrisey, Jonathan McCone

J Interferon Cytokine Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis